Carisma Therapeutics has filed documents with the Securities and Exchange Commission outlining plans to delist its stock. The University of Pennsylvania spinout is winding down operations. The filing was submitted on Monday. The company’s stock previously moved to the OTCID market after being suspended from Nasdaq trading in mid-October. Approval for the voluntary delisting and… Read more »